Peritransplant monitoring of immune cell function in adult living donor liver transplantation

S. Hwang, K. H. Kim, G. W. Song, Young-Dong Yu, G. C. Park, K. W. Kim, N. K. Choi, P. J. Park, Y. I. Choi, D. H. Jung, C. S. Ahn, D. B. Moon, T. Y. Ha, S. G. Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose We evaluated the clinical utility of peritransplant in vitro assays of immune cell function in adult living donor liver transplant (LDLT) recipients. Methods In particular, we measured immune cell function, using the ImmuKnow assay, in 107 adult LDLT recipients and 200 potential living liver donors (control group) admitted to our center between July 2008 and January 2009. Results In the control group, the mean proportion of T-helper/inducer cells was 36.8% ± 8.2%. The degree of immune response was strong in 12%, moderate in 77%, and low in 11%. In the study group, the degree of immune response within the first month was strong in 4.6%, moderate in 38.2%, and low in 57.2%, thus significantly lower than in the control group (P < .001). ImmuKnow results and tacrolimus levels did not show a significant correlation (r2 = .002, P = .392). Although six patients showed biopsy-proven acute cellular rejection, none showed a strong immune response. Patients with overt infection showed a lower immune response. Conclusions These results indicate that peritransplant assessment of immune response using the ImmuKnow assay does not reliably predict the occurrence of acute rejection. Additional studies are necessary to accurately assess the clinical utility of immune response monitoring.

Original languageEnglish
Pages (from-to)2567-2571
Number of pages5
JournalTransplantation Proceedings
Volume42
Issue number7
DOIs
Publication statusPublished - 2010 Sep 1
Externally publishedYes

Fingerprint

Immunologic Monitoring
Living Donors
Liver Transplantation
Control Groups
Liver
Tacrolimus
Helper-Inducer T-Lymphocytes
Biopsy
Infection
Transplant Recipients

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Peritransplant monitoring of immune cell function in adult living donor liver transplantation. / Hwang, S.; Kim, K. H.; Song, G. W.; Yu, Young-Dong; Park, G. C.; Kim, K. W.; Choi, N. K.; Park, P. J.; Choi, Y. I.; Jung, D. H.; Ahn, C. S.; Moon, D. B.; Ha, T. Y.; Lee, S. G.

In: Transplantation Proceedings, Vol. 42, No. 7, 01.09.2010, p. 2567-2571.

Research output: Contribution to journalArticle

Hwang, S, Kim, KH, Song, GW, Yu, Y-D, Park, GC, Kim, KW, Choi, NK, Park, PJ, Choi, YI, Jung, DH, Ahn, CS, Moon, DB, Ha, TY & Lee, SG 2010, 'Peritransplant monitoring of immune cell function in adult living donor liver transplantation', Transplantation Proceedings, vol. 42, no. 7, pp. 2567-2571. https://doi.org/10.1016/j.transproceed.2010.04.040
Hwang, S. ; Kim, K. H. ; Song, G. W. ; Yu, Young-Dong ; Park, G. C. ; Kim, K. W. ; Choi, N. K. ; Park, P. J. ; Choi, Y. I. ; Jung, D. H. ; Ahn, C. S. ; Moon, D. B. ; Ha, T. Y. ; Lee, S. G. / Peritransplant monitoring of immune cell function in adult living donor liver transplantation. In: Transplantation Proceedings. 2010 ; Vol. 42, No. 7. pp. 2567-2571.
@article{afa9872a1f354cbebcbb561273c05f85,
title = "Peritransplant monitoring of immune cell function in adult living donor liver transplantation",
abstract = "Purpose We evaluated the clinical utility of peritransplant in vitro assays of immune cell function in adult living donor liver transplant (LDLT) recipients. Methods In particular, we measured immune cell function, using the ImmuKnow assay, in 107 adult LDLT recipients and 200 potential living liver donors (control group) admitted to our center between July 2008 and January 2009. Results In the control group, the mean proportion of T-helper/inducer cells was 36.8{\%} ± 8.2{\%}. The degree of immune response was strong in 12{\%}, moderate in 77{\%}, and low in 11{\%}. In the study group, the degree of immune response within the first month was strong in 4.6{\%}, moderate in 38.2{\%}, and low in 57.2{\%}, thus significantly lower than in the control group (P < .001). ImmuKnow results and tacrolimus levels did not show a significant correlation (r2 = .002, P = .392). Although six patients showed biopsy-proven acute cellular rejection, none showed a strong immune response. Patients with overt infection showed a lower immune response. Conclusions These results indicate that peritransplant assessment of immune response using the ImmuKnow assay does not reliably predict the occurrence of acute rejection. Additional studies are necessary to accurately assess the clinical utility of immune response monitoring.",
author = "S. Hwang and Kim, {K. H.} and Song, {G. W.} and Young-Dong Yu and Park, {G. C.} and Kim, {K. W.} and Choi, {N. K.} and Park, {P. J.} and Choi, {Y. I.} and Jung, {D. H.} and Ahn, {C. S.} and Moon, {D. B.} and Ha, {T. Y.} and Lee, {S. G.}",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.transproceed.2010.04.040",
language = "English",
volume = "42",
pages = "2567--2571",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Peritransplant monitoring of immune cell function in adult living donor liver transplantation

AU - Hwang, S.

AU - Kim, K. H.

AU - Song, G. W.

AU - Yu, Young-Dong

AU - Park, G. C.

AU - Kim, K. W.

AU - Choi, N. K.

AU - Park, P. J.

AU - Choi, Y. I.

AU - Jung, D. H.

AU - Ahn, C. S.

AU - Moon, D. B.

AU - Ha, T. Y.

AU - Lee, S. G.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Purpose We evaluated the clinical utility of peritransplant in vitro assays of immune cell function in adult living donor liver transplant (LDLT) recipients. Methods In particular, we measured immune cell function, using the ImmuKnow assay, in 107 adult LDLT recipients and 200 potential living liver donors (control group) admitted to our center between July 2008 and January 2009. Results In the control group, the mean proportion of T-helper/inducer cells was 36.8% ± 8.2%. The degree of immune response was strong in 12%, moderate in 77%, and low in 11%. In the study group, the degree of immune response within the first month was strong in 4.6%, moderate in 38.2%, and low in 57.2%, thus significantly lower than in the control group (P < .001). ImmuKnow results and tacrolimus levels did not show a significant correlation (r2 = .002, P = .392). Although six patients showed biopsy-proven acute cellular rejection, none showed a strong immune response. Patients with overt infection showed a lower immune response. Conclusions These results indicate that peritransplant assessment of immune response using the ImmuKnow assay does not reliably predict the occurrence of acute rejection. Additional studies are necessary to accurately assess the clinical utility of immune response monitoring.

AB - Purpose We evaluated the clinical utility of peritransplant in vitro assays of immune cell function in adult living donor liver transplant (LDLT) recipients. Methods In particular, we measured immune cell function, using the ImmuKnow assay, in 107 adult LDLT recipients and 200 potential living liver donors (control group) admitted to our center between July 2008 and January 2009. Results In the control group, the mean proportion of T-helper/inducer cells was 36.8% ± 8.2%. The degree of immune response was strong in 12%, moderate in 77%, and low in 11%. In the study group, the degree of immune response within the first month was strong in 4.6%, moderate in 38.2%, and low in 57.2%, thus significantly lower than in the control group (P < .001). ImmuKnow results and tacrolimus levels did not show a significant correlation (r2 = .002, P = .392). Although six patients showed biopsy-proven acute cellular rejection, none showed a strong immune response. Patients with overt infection showed a lower immune response. Conclusions These results indicate that peritransplant assessment of immune response using the ImmuKnow assay does not reliably predict the occurrence of acute rejection. Additional studies are necessary to accurately assess the clinical utility of immune response monitoring.

UR - http://www.scopus.com/inward/record.url?scp=77956471566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956471566&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2010.04.040

DO - 10.1016/j.transproceed.2010.04.040

M3 - Article

VL - 42

SP - 2567

EP - 2571

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 7

ER -